生长抑素类似物（奥曲肽）用于新生儿术后乳糜胸的治疗：安全吗？
Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?
作者信息
Mohseni-Bod Hadi, Macrae Duncan, Slavik Zdenek
机构信息
Paediatric Intensive Care Unit, Royal Brompton & Harefield NHS Trust, Royal Brompton Hospital, London, UK.
出版信息
Pediatr Crit Care Med. 2004 Jul;5(4):356-7. doi: 10.1097/01.pcc.0000123552.36127.22.
OBJECTIVE
Somatostatin and its analogs have recently been introduced in the treatment of chylous effusions in infants and children following surgery. The safety profile of this treatment in critically ill patients has not been fully evaluated.
DESIGN
Retrospective case review.
SETTING
Tertiary pediatric cardiac center.
PATIENTS
A male infant born by cesarean section with a birth weight of 2.6 kg.
INTERVENTIONS
None.
CONCLUSIONS
We report the association of postoperative chylothorax treated with somatostatin analog (octreotide) and necrotizing enterocolitis in an infant following aortic coarctation repair.
目的
生长抑素及其类似物最近已被用于治疗婴幼儿术后乳糜胸。这种治疗方法在危重症患者中的安全性尚未得到充分评估。
设计
回顾性病例分析。
地点
三级儿科心脏中心。
患者
一名剖宫产出生的男婴，出生体重2.6千克。
干预措施
无。
结论
我们报告了一名婴儿在主动脉缩窄修复术后，使用生长抑素类似物（奥曲肽）治疗术后乳糜胸与坏死性小肠结肠炎之间的关联。
Zotero 插件